Evaluation of novel and alternative approaches to reduce the microbial load in river water with focus on reduction of microorganisms with impact on human and animal health

Evaluation of novel and alternative approaches to reduce the microbial load in river water with focus on reduction of microorganisms with impact on human and animal health (WP 3 "PAW Oxidation" and WP 4 "Phytotreatment")" within "MEDUWA Vecht(e)" project (EU/INTERREG)

Förderung

EU/INTERREG VA-142118 Funded as work package within the Dutch-German INTERREG cross border and inter-sectoral project "MEDUWA Vecht(e)" (lead partner Universität Osnabrück)

Projektleiter

K. Becker

Projektdauer

10/2016 – 06/2020

Inhalt/Content

The broad cross-border and inter-sectoral MEDUWA consortium operates within a shared river basin to address a common problem: the environmental cycle of human and veterinary medicines and multi-resistant bacteria that are transferred via drinking water, food and air back to humans and animals. This environmental cycling of contaminants is expected to be intensified by climate change. Interrupting this cycle not only brings benefits to the health of humans and animals. It makes the meat export-oriented economy less vulnerable to increasingly critical consumers and more stringent international legislation. In addition, cleaner soil and water reduces drinking water costs and is also beneficial for tourism, especially water recreation.

Links

MEDUWA Vecht(e)Interreg Deutschland-Nederland MEDUWA Vecht(e) / MEDUWA-News

 

 

OUR RECENT RESEARCH

Scheer CS et al. Blood culture practices and microbiological capacity for sepsis diagnostics in Europe (2021–2022): a cross-sectional analysis of the European Sepsis Care Survey The Lancet Regional Health - Europe Volume 62, March 2026, 101570

 

Cordovana M, Kostrzewa M, Bohnert JA, Eger E, Hübner NO, Becker K, Schaufler K, Heiden SE, Idelevich EA. Fourier-transform infrared spectroscopy reliably differentiates Klebsiella pneumoniae outbreak isolates. J Microbiol Methods. 2025; 240: 107355

 

Idelevich EA, Schlattmann A, Sauerland C, Gebert C, Becker K. Antimicrobial activity of copper-nickel coated door handles: a blinded, randomized controlled study in a clinical setting. GMS Hyg Infect Control. 2025;20:Doc47

 

Doğan E, Schaufler K, Heiden SE, Kohler C, Langheinrich M, Becker K, Eger E, Idelevich EA. Prevalence, characteristics and clinical features of hypervirulent Klebsiella pneumoniae in a German university hospital. Int J Med Microbiol. 2025; 320: 151662

 

Sydow K, Doğan E, Schwabe M, Heiden SE, Khan MM, Müller JU, Bohnert JA, Baecker D, Schlüter R, Schierack P, Eger E, Idelevich EA, Becker K, Schaufler K. Potential in-host evolution of Klebsiella pneumoniae ST147: convergence and the role of capsular alterations in morphotype diversity. Microbiol Spectr. 2025: e0017025

 

Idelevich EA, Becker K. Phagenendolysine – eine neue Wirkstoffklasse mit vielfältigen Einsatzmöglichkeiten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025; 68: 660-669

 

Scheer CS et al. Status of sepsis care in European hospitals: Results from an international cross-sectional survey. Am J Respir Crit Care Med. 2025; 211: 587-599